ArticleOncotarget2017

Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy.

Hanguang Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.